Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association between anti-PL7 antibodies and increased fibrotic component in patients with antisynthetase syndrome and interstitial lung disease: a cross-sectional study.
Rivero-Gallegos D, Mejía M, Rocha-González HI, Huerta-Cruz JC, Falfán-Valencia R, Ramos-Martínez E, Mateos-Toledo HN, Castillo-López MF, Rodríguez-Torres YK, Lira-Boussart V, Rojas-Serrano J. Rivero-Gallegos D, et al. Among authors: mateos toledo hn. Clin Rheumatol. 2024 Jun;43(6):1971-1978. doi: 10.1007/s10067-024-06965-w. Epub 2024 Apr 20. Clin Rheumatol. 2024. PMID: 38642252
Pulmonary manifestations and prognosis of a cohort of patients with interstitial lung disease and positive to anti-Th/To autoantibodies.
Mejía M, Ramos-Martínez E, Vázquez-Becerra LE, Fernández-Badillo D, Mateos-Toledo HN, Castillo J, Estrada A, Rojas-Serrano J. Mejía M, et al. Among authors: mateos toledo hn. Med Clin (Barc). 2024 Apr 26;162(8):378-384. doi: 10.1016/j.medcli.2023.11.023. Epub 2024 Jan 29. Med Clin (Barc). 2024. PMID: 38290874 English, Spanish.
Clinical risk factors in patients with interstitial lung disease associated with anti-MDA5 autoantibodies.
Ramos-Martinez E, Rodríguez-Vega EA, Rivera-Matias PA, Falfán-Valencia R, Pérez-Rubio G, Mejia M, González-Pérez MI, Buendia-Roldán I, Mateos-Toledo HN, Serrano JR. Ramos-Martinez E, et al. Among authors: mateos toledo hn. Med Clin (Barc). 2023 Dec 22;161(12):515-522. doi: 10.1016/j.medcli.2023.07.013. Epub 2023 Aug 9. Med Clin (Barc). 2023. PMID: 37567825 English, Spanish.
Interstitial lung disease progression in patients with anti-aminoacyl transfer-RNA-synthetase autoantibodies is characterized by higher levels of sCD163.
Ramos-Martínez E, Falfán-Valencia R, Pérez-Rubio G, Mejía M, Mejía-Hurtado JG, Buendía-Roldán I, González-Pérez MI, Mateos-Toledo HN, Rojas-Serrano J. Ramos-Martínez E, et al. Among authors: mateos toledo hn. Immunol Lett. 2022 Aug;248:56-61. doi: 10.1016/j.imlet.2022.06.007. Epub 2022 Jun 18. Immunol Lett. 2022. PMID: 35728747
Anti-Aminoacyl Transfer-RNA-Synthetases (Anti-tRNA) Autoantibodies Associated with Interstitial Lung Disease: Pulmonary Disease Progression has a Persistent Elevation of the Th17 Cytokine Profile.
Ramos-Martinez E, Falfán-Valencia R, Pérez-Rubio G, Mejia M, Buendía-Roldán I, González-Pérez MI, Mateos-Toledo HN, Rojas Serrano J. Ramos-Martinez E, et al. Among authors: mateos toledo hn. J Clin Med. 2020 May 6;9(5):1356. doi: 10.3390/jcm9051356. J Clin Med. 2020. PMID: 32384594 Free PMC article.